USDFA concludes inspection at Indoco’s Goa Plant

28 Jan 2019 Evaluate

US Food and Drug Administration (USFDA) has concluded inspection at Indoco Remedies’ Goa Plant I (Oral Dosages Facility) with issuing 6 observations (483s) to the site. None of these observations are critical in nature. The company will respond to these observations within the stipulated time of 15 days.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

212.90 -3.55 (-1.64%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×